Multiple listed companies issue positive and risk announcements on final day of National Day holiday

21世纪经济··CNUSEU·Read original
3▲1 ▼0Impact / 5
Summary · why it matters

On the final day of the National Day holiday, multiple listed companies issued positive announcements and risk warnings. Huahai Pharmaceutical announced that net profit attributable to shareholders of the listed company for the first three quarters of 2026 is expected to be between 1.028 billion yuan and 1.103 billion yuan, up 170% to 190% year on year, mainly due to a substantial increase in sales revenue from its active pharmaceutical ingredients business, expansion of products winning centralized procurement bids in the domestic formulations business, a turnaround to profitability in its US formulations business, gains from winning an arbitration case, and a reduction in research and development expenses. ZSP1601 tablets, a Class 1 innovative drug independently developed by Zhongshan Ruichuang, a controlling subsidiary of Zhongsheng Pharmaceutical, has been accepted into the breakthrough therapy designation procedure by the Center for Drug Evaluation of the National Medical Products Administration, with the proposed indication being metabolic dysfunction-associated steatohepatitis. The drug is a first-in-class innovative drug with global independent intellectual property rights. Yahong Medical signed a conditional exclusive licensing agreement with Theramex, under which Theramex will obtain exclusive rights to APL-1702 in European countries as well as Australia, New Zealand, and Turkey. Yahong Medical will receive an upfront payment of 15 million US dollars, a near-term regulatory milestone payment of 11 million US dollars, commercial milestone payments, and tiered sales royalties, with the total transaction value exceeding 250 million US dollars. Wuzhou Communications' controlling shareholder, Jiaotou Group, plans to increase its shareholding in the company within 12 months starting from October 8, 2026, with the proposed increase amount being no less than 89.045 million yuan and no more than 178 million yuan. Du Jinhao, the actual controller, chairman, and general manager of Allist, proposed that the company use its own funds to repurchase some A-shares, with the total repurchase amount being no less than 100 million yuan and no more than 200 million yuan. BYD Company announced on the Hong Kong Stock Exchange that its new energy vehicle sales in September were 463,561 units, up 16.98% year on year. On the same day, Feilong Auto Parts estimated that its net profit for the first three quarters of 2026 would be between 95 million yuan and 117 million yuan, down 59.20% to 66.87% year on year. Zhongke Haixun was banned by the naval procurement management department from participating in naval materials, engineering, and service procurement activities from September 23, 2026 to September 23, 2027, due to bid rigging and collusion violations in a certain assessment system procurement project. Zheng Chuangfa, the controlling shareholder and actual controller of Guanghua Technology, plans to reduce his shareholding by no more than 14.0581 million shares, or no more than 3% of the company's total share capital. Shi Zhongwei, the actual controller of Zhongya Stock, and his concert parties plan to reduce their combined shareholding by no more than 11.779 million shares.

Impact on assets 11

Off-coverage companies 1

Theramexi
Private± Mixedrelevance